Status:
UNKNOWN
Silymarin Cream Versus Salicylic Acid in Treatment of Acne Vulgaris
Lead Sponsor:
Assiut University
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Acne vulgaris is a disease of the pilosebaceous unit that causes noninflammatory lesions (open and closed comedones), inflammatory lesions (papules, pustules, and nodules), and varying degrees of scar...
Detailed Description
Chemical peeling is one of the most common cosmetic procedures in medical practice and has been used for decades. It is defined as the application of chemical agents, of variable strength, on the skin...
Eligibility Criteria
Inclusion
- Patients older than 18 years of age.
- Patients with mild and moderate acne vulgaris.
- Patients with Fitzpatrick skin type III, IV and V.
Exclusion
- Severe acne.
- Patients under treatment with contraceptive pills or any kind of systemic or topic acne medication (isotretinoin, antibiotics, topical products).
- History of hypertrophic/keloid scar formation.
- Pregnancy.
- Recurrent herpes infection.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04490967
Start Date
April 1 2021
End Date
December 1 2021
Last Update
March 12 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.